Menu Search
Equities

Kenvue Inc

KVUE:NYQ

Kenvue Inc

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)24.05
  • Today's Change-0.04 / -0.17%
  • Shares traded1.16m
  • 1 Year change+20.01%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 15:28 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy2
Outperform3
Hold11
Sell0
Strong Sell0

Share price forecast in USD

The 13 analysts offering 12 month price targets for Kenvue Inc have a median target of 25.00, with a high estimate of 27.00 and a low estimate of 21.00. The median estimate represents a 3.78% increase from the last price of 24.09.
High12.1%27.00
Med3.8%25.00
Low-12.8%21.00

Dividends in USD

In 2023, Kenvue Inc reported a dividend of 0.40 USD. The 11 analysts covering the company expect dividends of 0.81 USD for the upcoming fiscal year, an increase of 101.75%.
Div growth (TTM)--
More ▼

Earnings history & estimates in USD

On Nov 07, 2024, Kenvue Inc reported 3rd quarter 2024 earnings of 0.28 per share. This result was in line with the consensus of the 10 analysts following the company and under-performed last year's 3rd quarter results by 9.68%.
The next earnings announcement is expected on Feb 06, 2025.
Average growth rate-1.97%
Kenvue Inc reported annual 2023 earnings of 1.29 per share on Feb 08, 2024.
More ▼

Revenue history & estimates in USD

Kenvue Inc had 3rd quarter 2024 revenues of 3.90bn. This missed the 3.93bn consensus estimate of the 11 analysts following the company. This was 1.22% above the prior year's 3rd quarter results.
Average growth rate+0.01%
Kenvue Inc had revenues for the full year 2023 of 15.44bn. Last year the company did not report any revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.